Teses dirixidas (9) Teses que dirixiron as persoas membros do grupo

2024

  1. Advances in precision and safety of crispr-based gene targeting for primary hyperoxaluria type 1

    Torella, Laura

    Dirixida por Gloria González Aseguinolaza

2022

  1. Development of new strategies for the modulation of the immune response against gene therapy vectors

    ROS GAÑÁN, IRENE

    Dirixida por Mirja Hommel y Gloria González Aseguinolaza

2021

  1. Elucidating the mechanisms involved in liver damage and hepatitis B virus inhibition by hepatitis delta virus infection

    Camps Ramón, Gracián

    Dirixida por Rafael Aldabe Arregui y Gloria González Aseguinolaza
  2. Elucidating the mechanisms involved in HDV-induced pathogenesis

    Maestro Galilea, Sheila

    Dirixida por Gloria González Aseguinolaza y Rafael Aldabe Arregui
  3. Characterization of a Wilson Disease mouse model and development of novel therapies

    Barberia Urteaga, Miren

    Dirixida por Oihana Murillo Sauca y Gloria González Aseguinolaza

2019

  1. Characterization of new strategies to overcome the barrier of neutralizing antibodies in the aav-based gene therapy

    Salas Gómez, David

    Dirixida por Gloria González Aseguinolaza
  2. Glucocerebrosidase gene therapy in animal models of Parkinson Disease

    Sucunza, Diego

    Dirixida por José Luis Lanciego Pérez y Gloria González Aseguinolaza

2018

  1. Development of advanced genetic therapies for primary hyperoxaluria tipe I

    Zabaleta Lasarte, Nerea

    Dirixida por Gloria González Aseguinolaza y Juan Roberto Rodríguez Madoz
  2. Characterization of a mouse model for the study of hepatitis delta virus infection

    Usai, Carla

    Dirixida por Gloria González Aseguinolaza y Rafael Aldabe Arregui